US approves first Herceptin biosimilar
admin 4th December 2017 Uncategorised 0Mylan and Biocon’s Ogivri is the first biosimilar of Herceptin to win US approval, for certain breast cancer and metastatic stomach cancers.
More: US approves first Herceptin biosimilar
Source: News